Meglumine antimoniate

Leishmaniasis, a global health issue, lacks effective vaccines and chemotherapy, prompting research into new drugs, immunomodulators, and drug repositioning. Studies explore natural products like quercetin and apigenin, synthetic compounds, and combination therapies for treatment. Research highlights the need for improved therapeutic strategies, understanding immune responses, and addressing drug resistance and tolerance in Leishmania.